Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase IIa, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD2389 in Adult Participants With Steatotic Liver Disease and Advanced Fibrosis (BRAVO)

The purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (S…

Liver FibrosisHepatic Cirrhosis

Estimated

~$10 – $7,500

AstraZenecaNCT07610837